BamSEC and AlphaSense Join Forces
Learn More

Amgen Inc.

NASDAQ: AMGN    
Share price (11/21/24): $289.90    
Market cap (11/21/24): $156 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.2
from 8-K 4 pages Appendix 3 Conditions of the Acquisition and the Scheme
12/34/56
EX-2.1
from 8-K 105 pages Transaction Agreement Dated as of December 11, 2022 Among AMGEN Inc. Pillartree Limited and Horizon Therapeutics PLC
12/34/56
EX-2.1
from 8-K 80 pages Agreement and Plan of Merger Dated as of August 3, 2022 Among Chemocentryx, Inc., AMGEN Inc. and Carnation Merger Sub, Inc
12/34/56
EX-2.7
from 10-Q 107 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger Dated as of July 27, 2021 by and Among AMGEN Inc., Tuxedo Merger Sub, Inc., Teneobio, Inc., and Fortis Advisors LLC, as the Pre-Closing Holders’ Representative
12/34/56
EX-2.1
from 8-K 66 pages Agreement and Plan of Merger by and Among: AMGEN Inc., Franklin Acquisition Sub, Inc., and Five Prime Therapeutics, Inc. Dated as of March 4, 2021
12/34/56
EX-2.4
from 10-K 66 pages November 21, 2019 AMGEN Inc. One Amgen Center Drive, Thousand Oaks, California 91320 Attention: General Counsel Copy to Sullivan & Cromwell Llp 125 Broad Street, New York, Ny 10004 Attention: Francis J. Aquila; Matthew G. Hurd Re: Letter Agreement Re: Treatment of Certain Product Inventory Ladies and Gentlemen
12/34/56
EX-2.3
from 10-K 4 pages Amendment No. 2 to the Asset Purchase Agreement
12/34/56
EX-2.2
from 8-K 8 pages Irrevocable Guarantee
12/34/56
EX-2.1
from 8-K 119 pages Asset Purchase Agreement by and Among Celgene Corporation, as Seller, and AMGEN Inc., as Purchaser Dated as of August 25, 2019
12/34/56
EX-2.1
from 8-K 97 pages Agreement and Plan of Merger by and Among: Onyx Pharmaceuticals, Inc., a Delaware Corporation; AMGEN Inc., a Delaware Corporation; and Arena Acquisition Company, a Delaware Corporation Dated as of August 24, 2013
12/34/56
EX-2.1
from SC TO-C 97 pages Agreement and Plan of Merger by and Among: Onyx Pharmaceuticals, Inc., a Delaware Corporation; AMGEN Inc., a Delaware Corporation; and Arena Acquisition Company, a Delaware Corporation Dated as of August 24, 2013
12/34/56
EX-2.1
from 8-K 84 pages 24 April 2012 the Persons Listed in Part 3 of Schedule 1 as Mn Sellers (As Defined Herein) and the Persons Listed in Part 5 of Schedule 1 as Sihhat Sellers (As Defined Herein) and AMGEN Ilaç Tic. Ltd. Şti as Buyer and AMGEN Worldwide Holdings B.V. Share Purchase Agreement Mustafa Nevzat İlaç Sanayi̇i̇ Anoni̇m Şi̇rketi̇
12/34/56
EX-2.1
from 8-K 90 pages Agreement and Plan of Merger Among: Micromet, Inc., a Delaware Corporation; AMGEN Inc., a Delaware Corporation; and Armstrong Acquisition Corp., a Delaware Corporation Dated as of January 25, 2012
12/34/56
EX-2.1
from SC TO-C 90 pages Agreement and Plan of Merger Among: Micromet, Inc., a Delaware Corporation; AMGEN Inc., a Delaware Corporation; and Armstrong Acquisition Corp., a Delaware Corporation Dated as of January 25, 2012
12/34/56
EX-2.2
from 10-Q 6 pages Note: Redacted Portions Have Been Marked With [**]. the Redacted Portions Are Subject to a Request for Confidential Treatment That Has Been Filed With the Securities and Exchange Commission. First Amendment to the Agreement and Plan of Merger
12/34/56
EX-2.1
from 10-Q 159 pages Note: Redacted Portions Have Been Marked With [**]. the Redacted Portions Are Subject to a Request for Confidential Treatment That Has Been Filed With the Securities and Exchange Commission Agreement and Plan of Merger Among Biovex Group, Inc., Biovex Limited, AMGEN Inc., Andromeda Acquisition Corp. and Forbion 1 Management B.V. as the Stockholders’ Agent Dated as of January 24, 2011
12/34/56
EX-2
from SC 13D 15 pages Registration Rights Agreement
12/34/56
EX-2.1
from 8-K 74 pages Agreement and Plan of Merger by and Among AMGEN Inc., Aviator Merger Sub, Inc., Avidia, Inc. and Alloy Ventures, Inc., as Stockholders’ Agent Dated as of September 28, 2006
12/34/56
EX-2.1
from 8-K 77 pages Agreement and Plan of Merger Among Abgenix, Inc., AMGEN Inc. and Athletics Merger Sub, Inc. Dated as of December 14, 2005
12/34/56
EX-2.1
from 8-K 97 pages Agreement and Plan of Merger by and Among AMGEN Inc., Arrow Acquisition, LLC and Tularik Inc. Dated as of March 28, 2004
12/34/56